SCHEMBL5811315

SCHEMBL5811315

O=C(NC1CCCc2ccccc21)c1nn(-c2ccc(Cl)c(Cl)c2)c2c1CCC2

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.55
CNR2 P34972 2/20 0.55
TAS1R3 Q7RTX0 9/20 0.53
TAS1R1 Q7RTX1 9/20 0.53
TAS1R2 Q8TE23 8/20 0.53
ALDH1A1 P00352 2/20 0.53
DHODH Q02127 1/20 0.52
UGCG Q16739 1/20 0.52
HTT P42858 2/20 0.51
USP2 O75604 1/20 0.51
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C19 P33261 1/20 0.51
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5808194 0.91 LMNA (0.54) CNR1CNR2TAS1R3TAS1R1TAS1R2
SCHEMBL14003135 0.77 HTT (0.52) CNR2TAS1R3TAS1R1TAS1R2ALDH1A1
SCHEMBL5812049 0.75 CNR1 (0.69) CNR1CNR2ALDH1A1UGCGLMNA
SCHEMBL5811700 0.73 CNR2 (0.61) CNR1CNR2UGCG
SCHEMBL5806769 0.73 CNR2 (0.96) CNR1CNR2UGCG
SCHEMBL5811399 0.72 CNR1 (0.65) CNR1CNR2UGCG
SCHEMBL5808802 0.71 CNR1 (0.56) CNR1CNR2UGCG
SCHEMBL701934 0.70 TAS1R3 (1.00) TAS1R3TAS1R1TAS1R2ALDH1A1HTT
SCHEMBL5811149 0.69 CNR1 (0.59) CNR1CNR2UGCGCYP1A2CYP2D6
SCHEMBL16217845 0.69 KMO (0.56) CNR1CNR2TAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006030124-A1 CONDENSED PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME SANOFI-AVENTIS (FR) 2006-03-23 WO claimed